MiR-223 and miR-323 as biomarkers of inflammatory and neuropsychiatric alterations in long COVID with chronic viral hepatitis.
文献摘要
Long COVID involves persistent physical, mental, and functional symptoms following SARS-CoV-2 infection. Its biological mechanisms remain poorly understood, particularly with chronic viral hepatitis. This study investigated associations between microRNA (miRNA) expression and mental and physical health outcomes in individuals with Long COVID, considering chronic hepatitis B or C. This cross-sectional study included 80 individuals divided into four groups (n = 20 each): Long COVID, chronic viral hepatitis, Long COVID with hepatitis, and controls. Depression, anxiety, quality of life, fatigue, and functional status were assessed using validated scales, including the Post-COVID Functional Status Scale. Expression of miR-122, miR-143, miR-223, and miR-323 was quantified by RT-qPCR. Associations were evaluated using non-parametric tests and correlation analyses. MiR-143, miR-223, and miR-323 were significantly upregulated in individuals with Long COVID and hepatitis. MiRNA expression was associated with mental and physical health outcomes, particularly through a positive correlation between miR-323 expression and anxiety levels in individuals with Long COVID and hepatitis. MiR-223 was the only miRNA significantly overexpressed in this group compared with all other groups, suggesting its potential as a biomarker of coexisting conditions. Depression and anxiety affected up to 75% and 50% of individuals in the Long COVID groups, respectively (p < 0.05).These findings suggest that circulating miRNAs, particularly miR-223, miR-143, and miR-323, are associated with Long COVID in the presence of chronic viral hepatitis and may serve as biomarkers of disease burden and clinical heterogeneity.